VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q88406714 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241221010736.0
008 241221nneanz||abbn n and d
035 ‎‡a (WKP)Q88406714‏
024 ‎‡a 0000-0003-4213-1909‏ ‎‡2 orcid‏
035 ‎‡a (OCoLC)Q88406714‏
100 0 ‎‡a Young Ho Lee‏ ‎‡c researcher (ORCID 0000-0003-4213-1909)‏ ‎‡9 en‏
670 ‎‡a Author's Alcohol intake and risk of systemic lupus erythematosus: a Mendelian randomization study‏
670 ‎‡a Author's Assessing the causal association between smoking behavior and risk of gout using a Mendelian randomization study‏
670 ‎‡a Author's Association between CD40 polymorphisms and systemic lupus erythematosus and correlation between soluble CD40 and CD40 ligand levels in the disease: a meta-analysis‏
670 ‎‡a Author's Association between the interferon regulatory factor 5 rs2004640 functional polymorphism and systemic lupus erythematosus: an updated meta-analysis‏
670 ‎‡a Author's Associations between eNOS polymorphisms and susceptibility to Behcet’s disease: a meta‐analysis‏
670 ‎‡a Author's Associations between eNOS polymorphisms and susceptibility to Behcet's disease: a meta-analysis‏
670 ‎‡a Author's Associations between ERAP1 polymorphisms and ankylosing spondylitis susceptibility: a meta-analysis‏
670 ‎‡a Author's Associations between paraoxonase-1 and systemic lupus erythematosus‏
670 ‎‡a Author's Associations between paraoxonase 1 (PON1) polymorphisms and susceptibility and PON1 activity in rheumatoid arthritis patients, and comparison of PON1 activity in patients and controls: a meta-analysis‏
670 ‎‡a Author's Candidate gene studies of fibromyalgia: a systematic review and meta-analysis‏
670 ‎‡a Author's Causal association between body mass index and risk of rheumatoid arthritis: A Mendelian randomization study‏
670 ‎‡a Author's Causal association of gut microbiome on the risk of rheumatoid arthritis: a Mendelian randomisation study‏
670 ‎‡a Author's Causal relationship between years of education and the occurrence of rheumatoid arthritis‏
670 ‎‡a Author's Coffee consumption and the risk of rheumatoid arthritis and systemic lupus erythematosus: a Mendelian randomization study‏
670 ‎‡a Author's Comparative efficacy and safety of biosimilar-infliximab and originator-infliximab in combination with methotrexate in patients with active rheumatoid arthritis: a meta-analysis of randomized controlled trials‏
670 ‎‡a Author's Comparative Efficacy and Safety of Peficitinib 25, 50, 100, and 150 mg in Patients with Active Rheumatoid Arthritis: A Bayesian Network Meta-Analysis of Randomized Controlled Trials‏
670 ‎‡a Author's Comparative efficacy and safety of tofacitinib, baricitinib, upadacitinib, filgotinib and peficitinib as monotherapy for active rheumatoid arthritis‏
670 ‎‡a Author's Comparison of the efficacy and safety of tofacitinib and peficitinib in patients with active rheumatoid arthritis: A Bayesian network meta-analysis of randomized controlled trials‏
670 ‎‡a Author's Comparison of the efficacy and safety of tofacitinib and upadacitinib in patients with active rheumatoid arthritis: A Bayesian network meta-analysis of randomized controlled trials‏
670 ‎‡a Author's Correspondence on 'Systemic evaluation of the relationship between psoriasis, psoriatic arthritis and osteoporosis: observational and Mendelian randomisation study'‏
670 ‎‡a Author's CTLA-4 and TNF-α promoter-308 A/G polymorphisms and ANCA-associated vasculitis susceptibility: a meta-analysis‏
670 ‎‡a Author's Diabetes mellitus in ankylosing spondylitis‏
670 ‎‡a Author's Diagnosis of Paget’s disease of the pelvis using F‐18 FDG PET/CT‏
670 ‎‡a Author's Diagnosis of Paget's disease of the pelvis using F-18 FDG PET/CT.‏
670 ‎‡a Author's Efficacy and Safety of Monthly 150 mg Oral Ibandronate in Women with Postmenopausal Osteoporosis: A Systematic Review and Meta-analysis of Randomized Controlled Trials‏
670 ‎‡a Author's Gout and the risk of Alzheimer's disease: A Mendelian randomization study‏
670 ‎‡a Author's Impact of Janus kinase inhibitors on the risk of cardiovascular events in patients with rheumatoid arthritis: systematic review and meta-analysis of randomised controlled trials‏
670 ‎‡a Author's Investigating the possible causal association of coffee consumption with osteoarthritis risk using a Mendelian randomization analysis‏
670 ‎‡a Author's Meta-analysis of associations between interleukin-10 polymorphisms and susceptibility to Behcet's disease‏
670 ‎‡a Author's MiR-146a levels in rheumatoid arthritis and their correlation with disease activity: a meta-analysis‏
670 ‎‡a Author's Neutrophil-to-lymphocyte ratio, mean platelet volume and platelet-to-lymphocyte ratio in Behçet's disease and their correlation with disease activity: A meta-analysis‏
670 ‎‡a Author's The association between the PTPN22 C1858T polymorphism and systemic lupus erythematosus: a meta-analysis update‏
670 ‎‡a Author's The association between the PTPN22 C1858T polymorphism and systemic sclerosis: a meta-analysis‏
670 ‎‡a Author's The associations between interleukin-1 polymorphisms and susceptibility to ankylosing spondylitis: A meta-analysis‏
670 ‎‡a Author's The biallelic variable number of tandem repeats of the tumor necrosis factor receptor 2 promoter in systemic lupus erythematosus‏
670 ‎‡a Author's Uric acid level, gout and bone mineral density: A Mendelian randomization study‏
909 ‎‡a (orcid) 0000000342131909‏ ‎‡9 1‏
919 ‎‡a alcoholintakeandriskofsystemiclupuserythematosusamendelianrandomizationstudy‏ ‎‡A Alcohol intake and risk of systemic lupus erythematosus: a Mendelian randomization study‏ ‎‡9 1‏
919 ‎‡a causalassociationofgutmicrobiomeontheriskofrheumatoidarthritisamendelianrandomisationstudy‏ ‎‡A Causal association of gut microbiome on the risk of rheumatoid arthritis: a Mendelian randomisation study‏ ‎‡9 1‏
919 ‎‡a causalrelationshipbetweenyearsofeducationandtheoccurrenceofrheumatoidarthritis‏ ‎‡A Causal relationship between years of education and the occurrence of rheumatoid arthritis‏ ‎‡9 1‏
919 ‎‡a coffeeconsumptionandtheriskofrheumatoidarthritisandsystemiclupuserythematosusamendelianrandomizationstudy‏ ‎‡A Coffee consumption and the risk of rheumatoid arthritis and systemic lupus erythematosus: a Mendelian randomization study‏ ‎‡9 1‏
919 ‎‡a causalassociationbetweenbodymassindexandriskofrheumatoidarthritisamendelianrandomizationstudy‏ ‎‡A Causal association between body mass index and risk of rheumatoid arthritis: A Mendelian randomization study‏ ‎‡9 1‏
919 ‎‡a comparativeefficacyandsafetyofbiosimilarinfliximabandoriginatorinfliximabincombinationwithmethotrexateinpatientswithactiverheumatoidarthritisametaanalysisofrandomizedcontrolledtrials‏ ‎‡A Comparative efficacy and safety of biosimilar-infliximab and originator-infliximab in combination with methotrexate in patients with active rheumatoid arthritis: a meta-analysis of randomized controlled trials‏ ‎‡9 1‏
919 ‎‡a comparativeefficacyandsafetyofpeficitinib2550100and150mginpatientswithactiverheumatoidarthritisabayesiannetworkmetaanalysisofrandomizedcontrolledtrials‏ ‎‡A Comparative Efficacy and Safety of Peficitinib 25, 50, 100, and 150 mg in Patients with Active Rheumatoid Arthritis: A Bayesian Network Meta-Analysis of Randomized Controlled Trials‏ ‎‡9 1‏
919 ‎‡a comparativeefficacyandsafetyoftofacitinibbaricitinibupadacitinibfilgotinibandpeficitinibasmonotherapyforactiverheumatoidarthritis‏ ‎‡A Comparative efficacy and safety of tofacitinib, baricitinib, upadacitinib, filgotinib and peficitinib as monotherapy for active rheumatoid arthritis‏ ‎‡9 1‏
919 ‎‡a candidategenestudiesoffibromyalgiaasystematicreviewandmetaanalysis‏ ‎‡A Candidate gene studies of fibromyalgia: a systematic review and meta-analysis‏ ‎‡9 1‏
919 ‎‡a comparisonoftheefficacyandsafetyoftofacitinibandpeficitinibinpatientswithactiverheumatoidarthritisabayesiannetworkmetaanalysisofrandomizedcontrolledtrials‏ ‎‡A Comparison of the efficacy and safety of tofacitinib and peficitinib in patients with active rheumatoid arthritis: A Bayesian network meta-analysis of randomized controlled trials‏ ‎‡9 1‏
919 ‎‡a comparisonoftheefficacyandsafetyoftofacitinibandupadacitinibinpatientswithactiverheumatoidarthritisabayesiannetworkmetaanalysisofrandomizedcontrolledtrials‏ ‎‡A Comparison of the efficacy and safety of tofacitinib and upadacitinib in patients with active rheumatoid arthritis: A Bayesian network meta-analysis of randomized controlled trials‏ ‎‡9 1‏
919 ‎‡a correspondenceonsystemicevaluationoftherelationshipbetweenpsoriasispsoriaticarthritisandosteoporosisobservationalandmendelianrandomisationstudy‏ ‎‡A Correspondence on 'Systemic evaluation of the relationship between psoriasis, psoriatic arthritis and osteoporosis: observational and Mendelian randomisation study'‏ ‎‡9 1‏
919 ‎‡a ctla4andtnfαpromoter308agpolymorphismsandancaassociatedvasculitissusceptibilityametaanalysis‏ ‎‡A CTLA-4 and TNF-α promoter-308 A/G polymorphisms and ANCA-associated vasculitis susceptibility: a meta-analysis‏ ‎‡9 1‏
919 ‎‡a diabetesmellitusinankylosingspondylitis‏ ‎‡A Diabetes mellitus in ankylosing spondylitis‏ ‎‡9 1‏
919 ‎‡a diagnosisofpagetsdiseaseofthepelvisusingf18fdgpetct‏ ‎‡A Diagnosis of Paget’s disease of the pelvis using F‐18 FDG PET/CT‏ ‎‡9 2‏
919 ‎‡a efficacyandsafetyofmonthly150mgoralibandronateinwomenwithpostmenopausalosteoporosisasystematicreviewandmetaanalysisofrandomizedcontrolledtrials‏ ‎‡A Efficacy and Safety of Monthly 150 mg Oral Ibandronate in Women with Postmenopausal Osteoporosis: A Systematic Review and Meta-analysis of Randomized Controlled Trials‏ ‎‡9 1‏
919 ‎‡a impactofjanuskinaseinhibitorsontheriskofcardiovasculareventsinpatientswithrheumatoidarthritissystematicreviewandmetaanalysisofrandomisedcontrolledtrials‏ ‎‡A Impact of Janus kinase inhibitors on the risk of cardiovascular events in patients with rheumatoid arthritis: systematic review and meta-analysis of randomised controlled trials‏ ‎‡9 1‏
919 ‎‡a investigatingthepossiblecausalassociationofcoffeeconsumptionwithosteoarthritisriskusingamendelianrandomizationanalysis‏ ‎‡A Investigating the possible causal association of coffee consumption with osteoarthritis risk using a Mendelian randomization analysis‏ ‎‡9 1‏
919 ‎‡a metaanalysisofassociationsbetweeninterleukin10polymorphismsandsusceptibilitytobehcetsdisease‏ ‎‡A Meta-analysis of associations between interleukin-10 polymorphisms and susceptibility to Behcet's disease‏ ‎‡9 1‏
919 ‎‡a mir146alevelsinrheumatoidarthritisandtheircorrelationwithdiseaseactivityametaanalysis‏ ‎‡A MiR-146a levels in rheumatoid arthritis and their correlation with disease activity: a meta-analysis‏ ‎‡9 1‏
919 ‎‡a associationsbetweenparaoxonase1pon1polymorphismsandsusceptibilityandpon1activityinrheumatoidarthritispatientsandcomparisonofpon1activityinpatientsandcontrolsametaanalysis‏ ‎‡A Associations between paraoxonase 1 (PON1) polymorphisms and susceptibility and PON1 activity in rheumatoid arthritis patients, and comparison of PON1 activity in patients and controls: a meta-analysis‏ ‎‡9 1‏
919 ‎‡a associationsbetweenparaoxonase1andsystemiclupuserythematosus‏ ‎‡A Associations between paraoxonase-1 and systemic lupus erythematosus‏ ‎‡9 1‏
919 ‎‡a associationsbetweenerap1polymorphismsandankylosingspondylitissusceptibilityametaanalysis‏ ‎‡A Associations between ERAP1 polymorphisms and ankylosing spondylitis susceptibility: a meta-analysis‏ ‎‡9 1‏
919 ‎‡a associationsbetweenenospolymorphismsandsusceptibilitytobehcetsdiseaseametaanalysis‏ ‎‡A Associations between eNOS polymorphisms and susceptibility to Behcet's disease: a meta-analysis‏ ‎‡9 2‏
919 ‎‡a associationbetweentheinterferonregulatoryfactor5rs2004640functionalpolymorphismandsystemiclupuserythematosusanupdatedmetaanalysis‏ ‎‡A Association between the interferon regulatory factor 5 rs2004640 functional polymorphism and systemic lupus erythematosus: an updated meta-analysis‏ ‎‡9 1‏
919 ‎‡a neutrophiltolymphocyteratiomeanplateletvolumeandplatelettolymphocyteratioinbehcetsdiseaseandtheircorrelationwithdiseaseactivityametaanalysis‏ ‎‡A Neutrophil-to-lymphocyte ratio, mean platelet volume and platelet-to-lymphocyte ratio in Behçet's disease and their correlation with disease activity: A meta-analysis‏ ‎‡9 1‏
919 ‎‡a associationbetweentheptpn22c1858tpolymorphismandsystemiclupuserythematosusametaanalysisupdate‏ ‎‡A The association between the PTPN22 C1858T polymorphism and systemic lupus erythematosus: a meta-analysis update‏ ‎‡9 1‏
919 ‎‡a associationbetweentheptpn22c1858tpolymorphismandsystemicsclerosisametaanalysis‏ ‎‡A The association between the PTPN22 C1858T polymorphism and systemic sclerosis: a meta-analysis‏ ‎‡9 1‏
919 ‎‡a associationsbetweeninterleukin1polymorphismsandsusceptibilitytoankylosingspondylitisametaanalysis‏ ‎‡A The associations between interleukin-1 polymorphisms and susceptibility to ankylosing spondylitis: A meta-analysis‏ ‎‡9 1‏
919 ‎‡a biallelicvariablenumberoftandemrepeatsofthetumornecrosisfactorreceptor2promoterinsystemiclupuserythematosus‏ ‎‡A The biallelic variable number of tandem repeats of the tumor necrosis factor receptor 2 promoter in systemic lupus erythematosus‏ ‎‡9 1‏
919 ‎‡a uricacidlevelgoutandbonemineraldensityamendelianrandomizationstudy‏ ‎‡A Uric acid level, gout and bone mineral density: A Mendelian randomization study‏ ‎‡9 1‏
919 ‎‡a associationbetweencd40polymorphismsandsystemiclupuserythematosusandcorrelationbetweensolublecd40andcd40ligandlevelsinthediseaseametaanalysis‏ ‎‡A Association between CD40 polymorphisms and systemic lupus erythematosus and correlation between soluble CD40 and CD40 ligand levels in the disease: a meta-analysis‏ ‎‡9 1‏
919 ‎‡a assessingthecausalassociationbetweensmokingbehaviorandriskofgoutusingamendelianrandomizationstudy‏ ‎‡A Assessing the causal association between smoking behavior and risk of gout using a Mendelian randomization study‏ ‎‡9 1‏
919 ‎‡a goutandtheriskofalzheimersdiseaseamendelianrandomizationstudy‏ ‎‡A Gout and the risk of Alzheimer's disease: A Mendelian randomization study‏ ‎‡9 1‏
996 ‎‡2 LC|no2024050716‏
996 ‎‡2 ISNI|000000051364235X‏
996 ‎‡2 ISNI|0000000463569560‏
996 ‎‡2 ISNI|0000000385967992‏
996 ‎‡2 ISNI|0000000516904773‏
996 ‎‡2 NII|DA1408746X‏
996 ‎‡2 LC|n 2016031349‏
996 ‎‡2 ISNI|0000000468679603‏
996 ‎‡2 ISNI|0000000465099881‏
996 ‎‡2 ISNI|0000000029283818‏
996 ‎‡2 DNB|122658701‏
996 ‎‡2 ISNI|0000000468621057‏
996 ‎‡2 ISNI|0000000464867666‏
996 ‎‡2 ISNI|0000000480264224‏
996 ‎‡2 LC|no2022010778‏
996 ‎‡2 ISNI|0000000493005555‏
996 ‎‡2 ISNI|0000000479289934‏
996 ‎‡2 ISNI|000000046508863X‏
996 ‎‡2 LC|n 2023028740‏
996 ‎‡2 ISNI|0000000479088892‏
996 ‎‡2 ISNI|0000000473670494‏
996 ‎‡2 ISNI|0000000416463886‏
996 ‎‡2 DNB|1246762234‏
996 ‎‡2 LC|no2024018859‏
996 ‎‡2 DNB|1280869119‏
996 ‎‡2 ISNI|0000000467638914‏
996 ‎‡2 ISNI|0000000464858444‏
996 ‎‡2 ISNI|0000000468150734‏
996 ‎‡2 DNB|1019802766‏
996 ‎‡2 ISNI|000000046782774X‏
996 ‎‡2 ISNI|0000000033487573‏
996 ‎‡2 ISNI|0000000513672911‏
996 ‎‡2 ISNI|0000000473947078‏
996 ‎‡2 ISNI|000000046863267X‏
996 ‎‡2 ISNI|0000000463653340‏
996 ‎‡2 DNB|115444046X‏
996 ‎‡2 ISNI|0000000473970059‏
996 ‎‡2 ISNI|0000000480263264‏
996 ‎‡2 SUDOC|090865545‏
996 ‎‡2 ISNI|0000000081363647‏
996 ‎‡2 ISNI|0000000468539846‏
996 ‎‡2 ISNI|0000000052884742‏
996 ‎‡2 ISNI|0000000475049191‏
996 ‎‡2 ISNI|0000000475187308‏
996 ‎‡2 ISNI|0000000463276194‏
996 ‎‡2 BNF|16153186‏
996 ‎‡2 ISNI|0000000468644291‏
996 ‎‡2 ISNI|0000000494004394‏
996 ‎‡2 ISNI|0000000071469093‏
996 ‎‡2 ISNI|0000000464813246‏
996 ‎‡2 ISNI|000000046760364X‏
996 ‎‡2 ISNI|0000000493058147‏
996 ‎‡2 LC|n 85329679‏
996 ‎‡2 ISNI|0000000467605880‏
996 ‎‡2 ISNI|0000000473998414‏
996 ‎‡2 ISNI|0000000079110501‏
996 ‎‡2 DNB|1313528242‏
996 ‎‡2 ISNI|000000047398344X‏
996 ‎‡2 ISNI|0000000494076160‏
996 ‎‡2 ISNI|000000050469668X‏
996 ‎‡2 ISNI|0000000049195997‏
996 ‎‡2 ISNI|0000000084842512‏
996 ‎‡2 ISNI|0000000464686638‏
996 ‎‡2 LC|nr2003036986‏
996 ‎‡2 ISNI|0000000505538552‏
996 ‎‡2 JPG|500595228‏
996 ‎‡2 ISNI|0000000467636193‏
996 ‎‡2 ISNI|0000000494094836‏
996 ‎‡2 ISNI|0000000453843896‏
996 ‎‡2 ISNI|0000000504942641‏
996 ‎‡2 LC|no2013128337‏
996 ‎‡2 BIBSYS|98019475‏
996 ‎‡2 ISNI|0000000035868986‏
996 ‎‡2 ISNI|0000000459378286‏
996 ‎‡2 ISNI|0000000472388171‏
996 ‎‡2 ISNI|0000000480199442‏
996 ‎‡2 ISNI|0000000503909532‏
996 ‎‡2 ISNI|0000000474055303‏
996 ‎‡2 ISNI|0000000505292353‏
996 ‎‡2 ISNI|0000000474760176‏
996 ‎‡2 ISNI|0000000512293485‏
996 ‎‡2 NII|DA14505504‏
996 ‎‡2 ISNI|0000000460187153‏
996 ‎‡2 ISNI|0000000464673327‏
996 ‎‡2 ISNI|0000000473973962‏
996 ‎‡2 ISNI|0000000476724881‏
996 ‎‡2 LC|no2023105489‏
996 ‎‡2 BNF|15068105‏
996 ‎‡2 ISNI|0000000047887500‏
996 ‎‡2 ISNI|0000000459498595‏
996 ‎‡2 ISNI|0000000516893541‏
996 ‎‡2 ISNI|0000000477173401‏
996 ‎‡2 LC|nr 99028779‏
996 ‎‡2 ISNI|0000000476864155‏
996 ‎‡2 ISNI|0000000468639978‏
996 ‎‡2 ISNI|0000000468663337‏
996 ‎‡2 ISNI|000000047394888X‏
996 ‎‡2 ISNI|000000006914912X‏
996 ‎‡2 J9U|987007428950305171‏
996 ‎‡2 DNB|1332762018‏
996 ‎‡2 ISNI|0000000477779067‏
996 ‎‡2 ISNI|0000000467650323‏
996 ‎‡2 ISNI|0000000478996573‏
996 ‎‡2 ISNI|0000000110522839‏
996 ‎‡2 ISNI|0000000477654571‏
996 ‎‡2 ISNI|0000000464851605‏
996 ‎‡2 ISNI|0000000463274914‏
996 ‎‡2 ISNI|0000000473914313‏
996 ‎‡2 NSK|000431254‏
996 ‎‡2 ISNI|0000000480112095‏
996 ‎‡2 PLWABN|9810673686505606‏
996 ‎‡2 ISNI|0000000508092840‏
996 ‎‡2 NTA|44248366X‏
996 ‎‡2 DNB|172220769‏
996 ‎‡2 ISNI|0000000504174611‏
996 ‎‡2 ISNI|000000050481149X‏
996 ‎‡2 SUDOC|118718908‏
996 ‎‡2 DNB|143054821‏
996 ‎‡2 CAOONL|ncf11593088‏
996 ‎‡2 ISNI|0000000513537103‏
996 ‎‡2 ISNI|0000000464849839‏
996 ‎‡2 DNB|135941202‏
996 ‎‡2 ISNI|0000000505791750‏
996 ‎‡2 LC|n 2008007763‏
996 ‎‡2 ISNI|000000051351960X‏
996 ‎‡2 ISNI|0000000512502224‏
996 ‎‡2 ISNI|0000000492183704‏
996 ‎‡2 ISNI|0000000513721306‏
996 ‎‡2 DNB|1185525734‏
996 ‎‡2 ISNI|0000000048083539‏
996 ‎‡2 ISNI|0000000502805811‏
996 ‎‡2 ISNI|0000000505810149‏
996 ‎‡2 ISNI|000000047387629X‏
996 ‎‡2 BNF|16599048‏
996 ‎‡2 ISNI|0000000078732106‏
996 ‎‡2 LC|n 93094185‏
996 ‎‡2 NYNYRILM|357520‏
996 ‎‡2 ISNI|0000000030375373‏
996 ‎‡2 DNB|1158162952‏
996 ‎‡2 ISNI|0000000467818149‏
996 ‎‡2 ISNI|0000000467755037‏
996 ‎‡2 ISNI|0000000392262894‏
996 ‎‡2 ISNI|0000000512751730‏
996 ‎‡2 ISNI|0000000505544821‏
996 ‎‡2 NSK|000460772‏
996 ‎‡2 DNB|1203907346‏
996 ‎‡2 ISNI|0000000468407691‏
996 ‎‡2 LC|no2012000036‏
996 ‎‡2 DNB|123896975‏
996 ‎‡2 PLWABN|9813998730705606‏
996 ‎‡2 ISNI|0000000473693944‏
996 ‎‡2 ISNI|0000000512491334‏
996 ‎‡2 ISNI|0000000478994084‏
996 ‎‡2 DNB|1283669110‏
996 ‎‡2 ISNI|0000000473894930‏
996 ‎‡2 ISNI|0000000080605704‏
996 ‎‡2 ISNI|0000000493987296‏
996 ‎‡2 LC|no2009088372‏
996 ‎‡2 ISNI|0000000044576096‏
996 ‎‡2 ISNI|0000000473373756‏
996 ‎‡2 RERO|A024450641‏
996 ‎‡2 BNF|16569537‏
996 ‎‡2 LC|n 2018185107‏
996 ‎‡2 ISNI|0000000027145593‏
996 ‎‡2 SUDOC|263357341‏
996 ‎‡2 ISNI|0000000460976320‏
996 ‎‡2 ISNI|0000000474055784‏
996 ‎‡2 ISNI|0000000477008852‏
996 ‎‡2 LC|n 2018001859‏
996 ‎‡2 ISNI|0000000464889849‏
996 ‎‡2 ISNI|0000000494029962‏
996 ‎‡2 ISNI|0000000464710431‏
996 ‎‡2 LC|no2008047578‏
996 ‎‡2 ISNI|0000000464426115‏
996 ‎‡2 ISNI|0000000516885023‏
996 ‎‡2 ISNI|0000000516806559‏
996 ‎‡2 ISNI|0000000460272542‏
996 ‎‡2 ISNI|0000000504770173‏
996 ‎‡2 ISNI|000000049324533X‏
996 ‎‡2 ISNI|0000000491967048‏
996 ‎‡2 ISNI|0000000513220800‏
996 ‎‡2 ISNI|0000000505146671‏
996 ‎‡2 ISNI|0000000474026289‏
996 ‎‡2 ISNI|0000000408725698‏
996 ‎‡2 ISNI|0000000473514811‏
996 ‎‡2 LC|n 92023281‏
996 ‎‡2 LC|no 93016538‏
996 ‎‡2 ISNI|000000047957097X‏
996 ‎‡2 ISNI|0000000463620725‏
996 ‎‡2 ISNI|0000000110242853‏
996 ‎‡2 ISNI|0000000493018567‏
996 ‎‡2 ISNI|0000000513383765‏
996 ‎‡2 ISNI|0000000461030959‏
996 ‎‡2 DNB|1239441924‏
996 ‎‡2 ISNI|0000000479569936‏
996 ‎‡2 ISNI|0000000468652670‏
996 ‎‡2 ISNI|0000000046881131‏
996 ‎‡2 RERO|A017477716‏
996 ‎‡2 LC|n 79091716‏
996 ‎‡2 DNB|1208726382‏
996 ‎‡2 ISNI|0000000479100062‏
996 ‎‡2 ISNI|0000000476631407‏
996 ‎‡2 ISNI|0000000505916437‏
996 ‎‡2 ISNI|0000000467608432‏
996 ‎‡2 LC|nb2009022406‏
996 ‎‡2 ISNI|0000000477500185‏
996 ‎‡2 ISNI|0000000433875604‏
996 ‎‡2 ISNI|0000000467827790‏
996 ‎‡2 ISNI|0000000022039038‏
996 ‎‡2 DNB|121254160X‏
996 ‎‡2 LC|nr 99018102‏
996 ‎‡2 ISNI|0000000477129267‏
996 ‎‡2 ISNI|0000000479081543‏
996 ‎‡2 NUKAT|n 2004253463‏
996 ‎‡2 ISNI|0000000464526036‏
996 ‎‡2 ISNI|0000000461030609‏
996 ‎‡2 ISNI|0000000516875378‏
996 ‎‡2 NDL|033035959‏
996 ‎‡2 BNF|14568272‏
996 ‎‡2 ISNI|0000000478979538‏
996 ‎‡2 ISNI|0000000479316920‏
996 ‎‡2 ISNI|000000004478870X‏
996 ‎‡2 ISNI|0000000476833033‏
996 ‎‡2 ISNI|0000000460511195‏
996 ‎‡2 ISNI|0000000464780114‏
996 ‎‡2 LC|n 80126740‏
996 ‎‡2 ISNI|0000000465084639‏
996 ‎‡2 ISNI|0000000468044800‏
996 ‎‡2 ISNI|0000000463338295‏
996 ‎‡2 ISNI|0000000479311775‏
996 ‎‡2 DNB|171271971‏
996 ‎‡2 ISNI|0000000473563015‏
996 ‎‡2 LC|n 2013064668‏
996 ‎‡2 ISNI|0000000475245512‏
996 ‎‡2 NII|DA15584324‏
996 ‎‡2 ISNI|0000000139109706‏
996 ‎‡2 BNF|14434395‏
996 ‎‡2 BIBSYS|10034867‏
996 ‎‡2 ISNI|0000000503701256‏
996 ‎‡2 ISNI|000000046103102X‏
996 ‎‡2 ISNI|0000000082406370‏
996 ‎‡2 ISNI|0000000493092900‏
996 ‎‡2 ISNI|0000000493204669‏
996 ‎‡2 CAOONL|ncf11435226‏
996 ‎‡2 ISNI|0000000464623258‏
996 ‎‡2 ISNI|0000000464861790‏
996 ‎‡2 ISNI|0000000513487927‏
996 ‎‡2 LC|n 87148940‏
996 ‎‡2 ISNI|0000000512340616‏
996 ‎‡2 ISNI|000000047380355X‏
997 ‎‡a 0 0 lived 0 0‏ ‎‡9 1‏